In the context of "Pharmacology Made Easy 5.0," a test on the cardiovascular system would likely focus on the following key ...

A new clinical decision support tool for primary care providers (PCPs) led to a modest improvement in reinitiation of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers ...

MONDAY, Nov. 18, 2024 (HealthDay News) -- Metformin is associated with a lower rate of asthma attacks among people with diabetes, according to a study published online Nov. 18 in JAMA Internal ...

Panelists discuss how ARNIs like sacubitril-valsartan provide superior outcomes compared with ACE inhibitors in HFrEF (20% reduction in cardiovascular events, 16% mortality reduction), with broad FDA ...

The Interleukin-13 inhibitors market is witnessing robust growth, driven by the rising prevalence of atopic dermatitis, asthma, and other type 2 inflammatory diseases. Additionally, the expected ...

Angiotensin converting enzyme (ACE) inhibitors, a type of blood pressure medication, are usually well tolerated, but one of their rare side effects is angioedema. Angiotensin converting enzyme (ACE) ...

The MarketWatch News Department was not involved in the creation of this content. The TYK2 inhibitor market is expected to witness substantial growth in the coming years, driven by the increasing ...

As I was reviewing postoperative instructions with my patient after her extraction, she casually mentioned that she'd been taking "water pills" along with her blood pressure medication. My pen stopped ...

Mouse microglia got a genetic tune-up. On 9 June in Nature Aging, researchers led by Warren G. Tourtellotte at Cedars-Sinai Medical Center in Los Angeles reported that expressing human ...

Angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...

Acerand Therapeutics Initiates First-in-Human Phase I Clinical Trial of ACE-232, a Novel CYP11A1 Inhibitor for Advanced Prostate Cancer Acerand Therapeutics, a clinical-stage biotech company focusing ...